The College has partnered with Pfizer on an exciting grant opportunity to improve the ability of allergy practitioners to manage moderate to severe atopic dermatitis. Several grants of up to $350,000 will be awarded.
The goal of this joint ACAAI and Pfizer RFP grant program is to support projects that offer a comprehensive educational intervention to improve the ability of allergy practitioners to manage moderate to severe atopic dermatitis and specifically, demonstrate their ability to:
- Diagnose moderate to severe atopic dermatitis in different skin types and specifically skin of color.
- Make informed selection of therapies available now and in the pipeline, while managing the safety of and duration of treatment with systemic agents.
- Provide personalized care appropriate for differences in age and ethnicity.
- Educate patients on their role in successful disease management.
Refer to the complete details in the full RFP document. If you have questions regarding the RFP, please direct them in writing via email to Amanda Solis, grant officer.
The proposal deadline is October 28, 2021. An ACAAI review panel will make final grant decisions.
